Share class: Merck & Co., Inc.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A13,574,709,0222,528,032,964 ( 70.72 %) 1,045,073,377 ( 29.24 %) 70.72 %

Major shareholders: Merck & Co., Inc.

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.875 %
249,803,915 9.875 % 24 850 M $
BlackRock Advisors LLC
6.312 %
159,673,461 6.312 % 15 884 M $
State Street Corp.
4.705 %
119,026,412 4.705 % 11 841 M $
Wellington Trust Co., NA
2.997 %
75,809,383 2.997 % 7 542 M $
Geode Capital Management LLC
2.338 %
59,155,004 2.338 % 5 885 M $
Fidelity Management & Research Co. LLC
1.963 %
49,645,305 1.963 % 4 939 M $
BlackRock Life Ltd.
1.806 %
45,687,821 1.806 % 4 545 M $
Eaton Vance Management
1.755 %
44,391,822 1.755 % 4 416 M $
Merrill Lynch International
1.537 %
38,868,024 1.537 % 3 867 M $
Norges Bank (13F)
1.336 %
33,806,976 1.336 % 3 363 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
NameEquities%Valuation
Caixa DTVM SA
0.001356 %
274,370 0.001356 % 3 M $
Safra Asset Management Ltda.
0.000248 %
50,200 0.000248 % 613 667 $
BRAM - Bradesco Asset Management SA DTVM
0.000215 %
43,462 0.000215 % 531 299 $
XP Allocation Asset Management Ltda.
0.000069 %
13,916 0.000069 % 170 115 $

Breakdown by shareholder type

Institutional58.05%
Other11.94%
State Street Corp.4.71%
Swedbank AB0.30%
Schweizerische Nationalbank0.30%
Sumitomo Mitsui Trust Group, Inc.0.26%
Manulife Financial Corp.0.20%
Governments0.14%
Skandinaviska Enskilda Banken AB0.09%
SEI Investments Co.0.08%
Regions Financial Corp.0.06%
Rathbones Group Plc0.05%
The Bank of Nova Scotia0.05%
ING Groep NV0.04%
Fifth Third Bancorp0.03%
First Financial Bankshares, Inc.0.03%
Peapack-Gladstone Financial Corp.0.03%
Individuals0.03%
Zurich Insurance Group AG0.02%
Banco Bilbao Vizcaya Argentaria SA0.02%
Old Republic International Corp.0.02%
Corebridge Financial, Inc.0.02%
Fairfax Financial Holdings Ltd.0.01%
Associated Banc-Corp0.01%
Phoenix Financial Ltd.0.01%
Atlantic Union Bankshares Corp.0.01%
W.R. Berkley Corp.0.01%
Pinnacle Financial Partners, Inc.0.01%
Silvercrest Asset Management Group, Inc.0.01%
Cullen/Frost Bankers, Inc.0.01%
Commerzbank AG0.01%
Unknown23.44%

Based on 1000 largest holdings

Geographical origin of shareholders

United States 57.11%
United Kingdom 7.83%
Canada 2.72%
Norway 1.47%
France 1.22%
Sweden 1.01%
Australia 0.81%
Switzerland 0.72%
Japan 0.65%
Germany 0.50%
Denmark 0.46%
Netherlands 0.37%
Hong Kong 0.32%
South Korea 0.27%
Belgium 0.22%
Ireland 0.18%
Luxembourg 0.18%
Italy 0.13%
Finland 0.09%
Spain 0.07%
Austria 0.06%
Singapore 0.04%
Individuals 0.03%
Czech Republic 0.02%
New Zealand 0.02%
Israel 0.01%
Slovenia 0.01%
United Arab Emirates 0.01%
China 0.01%
South Africa 0.01%

Based on 1000 largest holdings

Logo Merck & Co., Inc.
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (67%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (22.1%); - sale of animal health products (9.4%); - other (1.5%). Net sales are distributed geographically as follows: the United States (47.4%), Europe/Middle East/Africa (22%), China (11.3%), Japan (5.3%), Asia/Pacific (5.4%), Latin America (5.1%) and other (3.5%).
Employees
71,000
Calendar
More about the company